Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 19

1.

Demystifying the ACE polymorphism: from genetics to biology.

Castellon R, Hamdi HK.

Curr Pharm Des. 2007;13(12):1191-8. Review.

PMID:
17504229
2.

Angiotensin I-converting enzyme insertion/deletion polymorphism: potential significance in nephrology.

Kitamura H, Moriyama T, Izumi M, Yokoyama K, Yamauchi A, Ueda N, Kamada T, Imai E.

Kidney Int Suppl. 1996 Jun;55:S101-3. Review.

PMID:
8743524
3.

The role of angiotensin-converting enzyme polymorphism in congestive heart failure.

Pilati M, Cicoira M, Zanolla L, Nicoletti I, Muraglia S, Zardini P.

Congest Heart Fail. 2004 Mar-Apr;10(2):87-93; quiz 94-5. Review.

5.

ACE polymorphisms.

Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JC.

Circ Res. 2006 May 12;98(9):1123-33. Review.

6.

ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?

Danser AH, Batenburg WW, van den Meiracker AH, Danilov SM.

Pharmacol Ther. 2007 Mar;113(3):607-18. Epub 2006 Dec 28. Review.

PMID:
17257685
7.

[Structure and function of angiotensin converting enzyme and its inhibitors].

Zhao Y, Xu C.

Sheng Wu Gong Cheng Xue Bao. 2008 Feb;24(2):171-6. Review. Chinese.

PMID:
18464595
8.

Molecular biology and genetics of the angiotensin-I-converting enzyme: potential implications in cardiovascular diseases.

Villard E, Soubrier F.

Cardiovasc Res. 1996 Dec;32(6):999-1007. Review. No abstract available.

9.

Angiotensin-converting enzyme gene in Alzheimer's disease.

Yang YH, Liu CK.

Tohoku J Exp Med. 2008 Aug;215(4):295-8. Review.

10.

Molecular biology of the angiotensin I converting enzyme: II. Structure-function. Gene polymorphism and clinical implications.

Soubrier F, Wei L, Hubert C, Clauser E, Alhenc-Gelas F, Corvol P.

J Hypertens. 1993 Jun;11(6):599-604. Review. No abstract available.

PMID:
8397238
11.

The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases.

Lazartigues E, Feng Y, Lavoie JL.

Curr Pharm Des. 2007;13(12):1231-45. Review.

PMID:
17504232
12.

Genetic factors in lung disease. Part II: Lung cancer and angiotensin converting enzyme gene.

Kawakami Y, Yamaguchi E, Munakata M, Dosaka-Akita H, Furuya K.

Respirology. 1997 Jun;2(2):81-90. Review. Erratum in: Respirology 1998 Mar;3(1):61.

PMID:
9441131
13.

[Role of angiotensin-converting enzyme gene polymorphism in the development of metabolic syndrome].

Roĭtberg GE, Tikhonravov AV, Dorosh ZhV.

Ter Arkh. 2003;75(12):72-7. Review. Russian. No abstract available.

PMID:
14959477
14.

[Cardiovascular diseases and gene polymorphisms].

Bartosová L, Strnadová V, Bartos M, Krcmár J, Necas J.

Cas Lek Cesk. 2006;145(9):695-700; discussion 700-1. Review. Czech.

PMID:
17091724
15.

Common genetic polymorphisms and coronary heart disease.

Keavney B.

Semin Vasc Med. 2002 Aug;2(3):233-41. Review.

PMID:
16222616
16.

Specific genetic markers of endurance performance and VO2max.

Hagberg JM, Moore GE, Ferrell RE.

Exerc Sport Sci Rev. 2001;29(1):15-9. Review.

PMID:
11210441
17.

[ACE: gene, biosynthesis and functions].

Ito M.

Nihon Rinsho. 2005 Mar;63 Suppl 3:22-7. Review. Japanese. No abstract available.

PMID:
15813039
18.

Genetics of pain: lessons for future studies.

Strong JA.

Int Anesthesiol Clin. 2007 Spring;45(2):13-25. Review. No abstract available.

PMID:
17426505
19.

Genetic polymorphism.

Ford EB.

Proc R Soc Lond B Biol Sci. 1966 Mar 22;164(995):350-61. Review. No abstract available.

PMID:
4379524
Items per page

Supplemental Content

Write to the Help Desk